Tyler Stone Wealth Management increased its holdings in shares of CVS Health Co. (NYSE:CVS – Free Report) by 83.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 10,169 shares of the pharmacy operator’s stock after acquiring an additional 4,632 shares during the period. Tyler Stone Wealth Management’s holdings in CVS Health were worth $639,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of the business. Livelsberger Financial Advisory purchased a new position in shares of CVS Health in the 3rd quarter valued at about $31,000. Reston Wealth Management LLC purchased a new position in CVS Health in the third quarter valued at about $32,000. First Community Trust NA lifted its position in shares of CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after acquiring an additional 302 shares during the period. Kathleen S. Wright Associates Inc. acquired a new stake in shares of CVS Health in the 3rd quarter worth approximately $33,000. Finally, ORG Partners LLC increased its stake in CVS Health by 11,840.0% in the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 592 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.
Analysts Set New Price Targets
A number of analysts have commented on CVS shares. Wells Fargo & Company decreased their target price on CVS Health from $61.00 to $60.00 and set an “equal weight” rating on the stock in a research report on Monday, November 4th. UBS Group increased their price objective on shares of CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a research note on Thursday. Evercore ISI lifted their target price on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a research report on Tuesday, October 1st. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Nine research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and an average price target of $73.00.
CVS Health Price Performance
CVS opened at $55.54 on Monday. CVS Health Co. has a 1 year low of $52.77 and a 1 year high of $83.25. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.66 and a current ratio of 0.80. The company’s 50 day simple moving average is $59.56 and its 200 day simple moving average is $59.12. The stock has a market capitalization of $69.89 billion, a PE ratio of 14.10, a P/E/G ratio of 0.88 and a beta of 0.55.
CVS Health (NYSE:CVS – Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the company earned $2.21 EPS. As a group, sell-side analysts expect that CVS Health Co. will post 5.63 EPS for the current year.
CVS Health Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.79%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s dividend payout ratio is currently 67.51%.
CVS Health Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Articles
- Five stocks we like better than CVS Health
- The How and Why of Investing in Gold Stocks
- California Resources Stock Could Be a Huge Long-Term Winner
- How Technical Indicators Can Help You Find Oversold StocksĀ
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- Are Penny Stocks a Good Fit for Your Portfolio?
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.